LabCompass

Shakti Ranjan Satapathy

Medicine · Purdue University West Lafayette

Mid career · publishing since 2012

Publications

62

Citations

1,493

Est. group size

Recurring co-author estimate

Active years

15

Publishing since 2012

Research summary
AI-generated

This researcher studies the molecular biology of colorectal and other cancers, focusing on how inflammatory signaling molecules, hormone receptors, and immune checkpoint proteins interact to drive tumor growth, drug resistance, and metastasis. Much of the work examines specific molecular pathways (such as WNT signaling, PD-L1, estrogen receptors, and leukotriene receptors) as potential biomarkers or drug targets for improving cancer prognosis and treatment. The research combines laboratory cell studies with patient-derived data and model organisms like zebrafish to test these findings.

Colorectal cancer biologyImmune checkpoint (PD-L1) and inflammation in cancerHormone receptors (estrogen) in cancer prognosisWNT signaling and microRNA regulation in tumorsDrug resistance and metastasis mechanisms

Publication output rose to a peak around 2019 (9 papers) then declined through the early 2020s, with a recent uptick in 2025, averaging about 3.2 papers per year over the last five years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 3.2/year recently
2017: 1 publication172018: 5 publications182019: 9 publications9192020: 7 publications202021: 3 publications212022: 3 publications222023: 2 publications232024: 4 publications242025: 6 publications252026: 1 publication26
Recent publications
Publishes in
  • Cancer Research×5
  • Cancer Letters×4
  • Cell Communication and Signaling×3
  • Cancers×3
  • Annals of Oncology×3
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 20, 2026.

Claim or correct this profile